Elsevier

American Heart Journal

Volume 168, Issue 2, August 2014, Pages 213-219.e1
American Heart Journal

Clinical Investigation
Cardiovascular Epidemiology
Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: Insights from the ClinicalTrials.gov registry

https://doi.org/10.1016/j.ahj.2014.04.013Get rights and content

Background

Early termination of clinical trials due to low recruitment represents an understudied challenge for clinical research. We aimed to describe characteristics of cardiovascular trials terminated because of low recruitment and identify the major predictors of such early termination.

Methods

We reviewed all cardiovascular clinical trials (7,042 studies) registered in ClinicalTrials.gov from February 29, 2000, to January 17, 2013, and assessed information about trials that were completed and those that were terminated early. Logistic regression models were developed to identify independent predictors of early termination due to low recruitment.

Results

Our search strategy identified 6,279 cardiovascular clinical trials, of which 684 (10.9%) were terminated prematurely. Of these halted trials, the main reason for termination was lower than expected recruitment (278 trials; 53.6%). When comparing trials that terminated early because of low recruitment with those that were completed, we found that studies funded by the National Institutes of Health or other US federal agencies (odds ratio [OR] 0.35, 95% confidence interval [CI] 0.14-0.89), studies of behavior/diet intervention (OR 0.35, 95% CI 0.19-0.65), and single-arm design studies (OR 0.57, 95% CI 0.42-0.78) were associated with a lower risk of early termination. University/hospital-funded (OR 1.52, 95% CI 1.10-2.10) and mixed-source–funded studies (OR 2.14, 95% CI 1.52-3.01) were associated with a higher likelihood of early termination due to lower than expected recruitment rates.

Conclusions

Low recruitment represents the main cause of early termination of cardiovascular clinical trials. Funding source, type of intervention, and study design are factors associated with early termination due to low recruitment and might be good targets for improving enrollment into cardiovascular clinical trials.

Section snippets

ClinicalTrials.gov

The methods and quality assurance strategies used by ClinicalTrials.gov to register trials have been described in detail previously.5, 6 ClinicalTrials.gov was developed and is maintained by the National Library of Medicine on behalf of the National Institutes of Health (NIH). ClinicalTrials.gov uses a Web-based system to facilitate registration of clinical trials by the study sponsor or the principal investigator and includes both mandatory and optional data elements.7

Eligibility criteria and search strategy

We searched the

Results

Our search strategy retrieved 7,042 trials, from which we were able to identify 6,279 studies that met the inclusion criteria of cardiovascular clinical trials registered in ClinicalTrials.gov between February 29, 2000, and January 17, 2013. From the eligible trials, 5,595 (89.1%) were classified as completed and 684 (10.9%) trials as terminated.

From the total of terminated trials, 165 trials (24.1%) did not report the reason for their early termination. After performing a Medline search, we

Discussion

Our study showed that, among a contemporary cohort of cardiovascular clinical trials registered in ClinicalTrials.gov, more than 10% were terminated prematurely. The most common reason for early termination was lower than expected recruitment rates. Factors associated with lower risk of early termination due to low recruitment were funding by the NIH or other US federal agencies as well as trials assessing behavioral or dietary interventions and those with a single-arm design. On the other

Disclosures

Sources of funding: No extramural funding was used to support this work.

Acknowledgements

We thank Peter Hoffmann of the Duke Clinical Research Institute for his editorial contribution to this manuscript.

References (24)

  • R Core Team

    R: a language and environment for statistical computing

  • AACT Database

    Clinical Trials Transformation Initiative Web site

  • Cited by (0)

    Charles Maynard, PhD, served as guest editor for this article.

    View full text